Učitavanje...
A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma
Multiple myeloma is an incurable cancer of bone marrow plasma cells, with a 5-year survival rate of 43%. Its incidence has increased by 126% since 1990. Treatment typically involves high-dose combination chemotherapy, but therapeutic response and patient survival are unpredictable and highly variabl...
Spremljeno u:
| Izdano u: | Blood Cancer J |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7070076/ https://ncbi.nlm.nih.gov/pubmed/32170169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-0304-7 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|